Potential for imaging cerebral amyloid deposits using 123I-labelled serum amyloid p component and spet

Nuclear Medicine Communications

Volumn 17, Issue 11, 1996, Pages 929-934

  Bornebroek, M ^a   Verzijlbergen, J F ^b   Haan, J ^a,c   Van Scheyen, E J ^c   Verhoeff, N P L G ^d   Pauwels, E K J ^a   Roos, R A C ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ST ANTONIUS HOSPITAL   (Netherlands)

^c RIJNLAND HOSPITAL   (Netherlands)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID P COMPONENT; IODINE 123;

ADULT; AMYLOIDOSIS; ARTICLE; CASE REPORT; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; DRUG CLEARANCE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

BRAIN; CEREBRAL AMYLOID ANGIOPATHY; CEREBRAL CORTEX; HUMANS; IODINE RADIOISOTOPES; MAGNETIC RESONANCE IMAGING; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; REFERENCE VALUES; SERUM AMYLOID P-COMPONENT; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0029801982     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1080/00006231-199611000-00002     Document Type: Article

References (14)

1. Pepys MB. Amyloidosis: Some recent developments. Quart J Med 1988; 67: 283-298.
2. Pepys MB, Rademacher TW, Amatuyakul-Chantler S et al. Human serum amyloid P component is an invariant constituent of amyloid deposits and has a uniquely homogeneous glycostructure. Proc Natl Acad Sci 1994; 91: 5602-5606.
3. Coria F, Castano E, Prelli F et al Isolation and characterization of amyloid P component from Alzheimer’s disease and other types of cerebral amyloiodosis. Lab Invest 1988; 58: 454-458.
4. Hawkins PN, Myers MJ, Lavender JP, Pepys MB. Diagnostic radionuclide imaging of amyloid: Biological targeting by circulating human serum amyloid P component. Lancet 1988; 1: 1413-1418.
5. Hawkins PN, Lavender JP, Pepys MB. Evaluation of systemic amyloidosis by scintigraphy with 123I-labelled serum amyloid P component. Nezv Engl J Med 1990; 323: 508-513.
6. Nelson SR, Hawkins PN, Richardson S et al. Imaging of haemodialysis-associated amyloidosis with 123I-serum amyloid P component. Lancet 1991; 338: 335-338.
7. Hawkins PN, Richardson S, MacSweeney JE et al. Scintigraphic quantification and serial monitoring of human visceral amyloid deposits provide evidence for turnover and regression. Quart J Med 1993; 86: 365-374.
8. Hawkins PN, Pepys MB. Imaging amyloidosis with radiolabelled SAP. Eur J Nucl Med 1995; 22: 595-599.
9. Hawkins PN. Studies with radiolabelled serum amyloid P component provide evidence for turnover and regression of amyloid deposits in vivo. Clin Sci 1994; 87: 289-295.
10. Joachim CL, Morris JH, Selkoe DJ. Clinically diagnosed Alzheimer’s disease: Autopsy results in 150 cases. Ann Neurol 1988; 24: 50-56.
11. Luyendijk W, Bots GTAM, Vegter van der Vlis M, Went LN, Frangione B. Hereditary cerebral hemorrhage caused by cortical amyloid angiopathy. J Neurol Sci 1988; 85: 267-280.
12. Haan J, Roos RAC, Algra PR, Lanser JBK, Bots GTAM, Vegter van der Vlis M. Hereditary cerebral hemorrhage with amyloidosis-Dutch type: Magnetic resonance imaging findings of seven patients. Brain 1990; 113: 1251-1267.
13. Maat-Schieman MLC, van Duinen SG, Haan J, Roos RAC. Morphology of cerebral plaque-like lesions in hereditary cerebral hemorrhage with amyloidosis (Dutch). Acta Neuro-pathol 1992; 84: 674-679.
14. Bakker E, Van Broeckhoven C, Haan J et al. DNA diagnosis for hereditary cerebral hemorrhage with amyloidosis (Dutch type). Am J Hum Genet 1991; 49: 518-521.